TM6SF2 and Hepatic fibrosis: In this study, we explore the significance of BAG3 detection in patients’ sera in hepatic fibrosis within the context of MASLD and its interaction with key genetic variants PNPLA3 and TM6SF2, aiming to unravel potential new insights into the molecular mechanisms driving disease progression.